Cardiovascular disease (CVD), which includes chronic conditions affecting the heart and blood vessels such as heart failure, heart attacks and strokes, is the world's leading cause of death and one of society's biggest health concerns.
Immunology covers a broad spectrum of conditions, including chronic skin diseases such as psoriasis and hidradenitis suppurativa. Autoimmune conditions alone, which form a small part of immunological diseases, affect an estimated 4.5% of the world’s population and their prevalence is increasing.
Cancer is the second leading cause of death worldwide. The World Health Organization (WHO) estimates there will be 50% more new cancer cases in 2040 than there are today. At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.
From the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples lives.
Benefiting from our continued focus on innovation. Novartis has one of the industry's most competitive pipelines.
List of the treatments we currently offer via our Innovative Medicines Division.